Annual report
7317.TEDINET S100R54J
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥7.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥355m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥409m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥831m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥381m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥223m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥671m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥292m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥165m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥569m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥223m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥114m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥165m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.8bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥739m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥529m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥915m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥140m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥656m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥220m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥485m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥42m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥120m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥504m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥43m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥36m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥331m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥80.67 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.42 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.83 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.56 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.26 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥80.09 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.99 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥107.49 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥714.77 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥613.76 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥538.84 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥445.01 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥395.07 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 43.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,383 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,442 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,422 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,370 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,371 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥139m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥32m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥68m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥31m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥673m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥78m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥261m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥438,000 | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥320m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥4m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥469m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥20m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥42m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.7bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥567m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥547m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥913m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥851m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-60.65 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.79 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.69 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.53 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥88.76 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥189.62 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥254.33 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥255.6 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥126.05 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥121.52 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 24.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -27.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 49.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,281,800 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,275,400 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,598,500 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,250,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,250,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 39 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 33 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 30 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | segment assets | at 2023-03-31 | ¥11m |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥533,000 |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥262m |
| Medical Healthcarereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥711m |
| Medical Healthcarereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥71m |
| Medical Healthcarereportable segment | employees | at 2023-03-31 | 663 pure |
| Medical Healthcarereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | segment assets | at 2023-03-31 | ¥3.4bn |
| Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥194m |
| Safety Systemreportable segment | employees | at 2023-03-31 | 712 pure |
| Safety Systemreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | segment assets | at 2023-03-31 | ¥4.2bn |
| Safety Systemreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥349m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥265m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥874m |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥49m |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥49m |
| Otherother segments | segment assets | at 2022-03-31 | ¥21m |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥8m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥32m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥267m |
| Medical Healthcarereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥139m |
| Medical Healthcarereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥77m |
| Medical Healthcarereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.3bn |
| Medical Healthcarereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.3bn |
| Medical Healthcarereportable segment | segment assets | at 2022-03-31 | ¥2.5bn |
| Medical Healthcarereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥960m |
| Safety Systemreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥403m |
| Safety Systemreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥149m |
| Safety Systemreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Safety Systemreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Safety Systemreportable segment | segment assets | at 2022-03-31 | ¥3.4bn |
| Safety Systemreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥330m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥541m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥622m |
| Medical Healthcarereportable segment | employees | at 2023-03-31 | 12 pure |
| Safety Systemreportable segment | employees | at 2023-03-31 | 19 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,374
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in financing activities | Prior1YearDuration | 504066000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 1220017000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 10866000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | -3697000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 170683000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 851468000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1296757000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1467441000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1467441000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 2318909000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 4 | |
| Accumulated depreciation ppe by group | Prior1YearInstant | -1182332000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -1517074000 | JPY |
| Directors compensations sga | Prior1YearDuration | 128039000 | JPY |
| Directors compensations sga | CurrentYearDuration | 118964000 | JPY |
| Employee payrolls and allowances sga | Prior1YearDuration | 188577000 | JPY |
| Employee payrolls and allowances sga | CurrentYearDuration | 210884000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 15297000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 8251000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 5596000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 15871000 | JPY |
| Freightage and packing expenses sga | Prior1YearDuration | 113414000 | JPY |
| Freightage and packing expenses sga | CurrentYearDuration | 71238000 | JPY |
| Business consignment expenses sga | Prior1YearDuration | 57391000 | JPY |
| Business consignment expenses sga | CurrentYearDuration | 44679000 | JPY |
| Write downs of inventories | Prior1YearDuration | 99738000 | JPY |
| Write downs of inventories | CurrentYearDuration | 238366000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 43419000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 47730000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E35560-000MedicalHealthcareReportableSegmentMember | 4302103000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E35560-000SafetySystemReportableSegmentMember | 1289383000 | JPY |
| Revenues from external customers | Prior1YearDuration_OtherReportableSegmentsMember | 48849000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 5640337000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 5640337000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E35560-000MedicalHealthcareReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E35560-000SafetySystemReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_OtherReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E35560-000MedicalHealthcareReportableSegmentMember | 4302103000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E35560-000SafetySystemReportableSegmentMember | 1289383000 | JPY |
| Net sales | Prior1YearDuration_OtherReportableSegmentsMember | 48849000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 5640337000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 5640337000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E35560-000MedicalHealthcareReportableSegmentMember | 960288000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E35560-000SafetySystemReportableSegmentMember | -330190000 | JPY |
| Operating income | Prior1YearDuration_OtherReportableSegmentsMember | -8033000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |